{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:42:34Z","timestamp":1794120154384,"version":"4.8.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41574-018-0123-0","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T16:36:35Z","timestamp":1542818195000},"page":"9-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":262,"title":["Inter-tissue communication in cancer cachexia"],"prefix":"10.1038","volume":"15","author":[{"given":"Josep M.","family":"Argil\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Stemmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"L\u00f3pez-Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Busquets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"123_CR1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans, W. J. et al. Cachexia: a new definition. Clin. Nutr. 27, 793\u2013799 (2008).","journal-title":"Clin. Nutr."},{"key":"123_CR2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s, J. M., Busquets, S., Stemmler, B. & L\u00f3pez-Soriano, F. J. Cancer cachexia: understanding the molecular basis. Nat. Rev. Cancer 14, 754\u2013762 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"123_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12, 489\u2013495 (2011).","journal-title":"Lancet Oncol."},{"key":"123_CR4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.7861\/clinmedicine.6-2-140","volume":"6","author":"GD Stewart","year":"2006","unstructured":"Stewart, G. D., Skipworth, R. J. & Fearon, K. C. Cancer cachexia and fatigue. Clin. Med. 6, 140\u2013143 (2006).","journal-title":"Clin. Med."},{"key":"123_CR5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00000441-193211000-00002","volume":"184","author":"S Warren","year":"1932","unstructured":"Warren, S. The immediate cause of death in cancer. Am. J. Med. Sci. 184, 610\u2013613 (1932).","journal-title":"Am. J. Med. Sci."},{"key":"123_CR6","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.4081\/ejtm.2018.7587","volume":"28","author":"D Coletti","year":"2018","unstructured":"Coletti, D. Chemotherapy-induced muscle wasting: an update. Eur. J. Transl Myol. 28, 7587 (2018).","journal-title":"Eur. J. Transl Myol."},{"key":"123_CR7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","volume":"69","author":"WD Dewys","year":"1980","unstructured":"Dewys, W. D. et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am. J. Med. 69, 491\u2013497 (1980).","journal-title":"Am. J. Med."},{"key":"123_CR8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/13696998.2016.1181640","volume":"19","author":"ST Arthur","year":"2016","unstructured":"Arthur, S. T. et al. Cachexia among US cancer patients. J. Med. Econ. 19, 874\u2013880 (2016).","journal-title":"J. Med. Econ."},{"key":"123_CR9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.clnu.2016.05.010","volume":"36","author":"JM Argil\u00e9s","year":"2016","unstructured":"Argil\u00e9s, J. M. The 2015 ESPEN Sir David Cuthbertson lecture: Inflammation as the driving force of muscle wasting in cancer. Clin. Nutr. 36, 798\u2013803 (2016).","journal-title":"Clin. Nutr."},{"key":"123_CR10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1615\/CritRevOncog.v17.i3.30","volume":"17","author":"JM Argil\u00e9s","year":"2012","unstructured":"Argil\u00e9s, J. M., L\u00f3pez-Soriano, F. J. & Busquets, S. Counteracting inflammation: a promising therapy in cachexia. Crit. Rev. Oncog. 17, 253\u2013262 (2012).","journal-title":"Crit. Rev. Oncog."},{"key":"123_CR11","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","volume":"303","author":"A Bonetto","year":"2012","unstructured":"Bonetto, A. et al. JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am. J. Physiol. Endocrinol. Metab. 303, E410\u2013E421 (2012).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"123_CR12","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.3390\/nu7064465","volume":"7","author":"RG Camargo","year":"2015","unstructured":"Camargo, R. G. et al. NF-\u03baBp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients. Nutrients 7, 4465\u20134479 (2015).","journal-title":"Nutrients"},{"key":"123_CR13","doi-asserted-by":"crossref","unstructured":"Waning, D. L. & Guise, T. A. Molecular Mechanisms of Bone Metastasis and Associated Muscle Weakness. Clin. Cancer Res. 20, 3071\u20133077 (2014)","DOI":"10.1158\/1078-0432.CCR-13-1590"},{"key":"123_CR14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2217\/fon.10.20","volume":"6","author":"MJ Tisdale","year":"2010","unstructured":"Tisdale, M. J. Are tumoral factors responsible for host tissue wasting in cancer cachexia? Future Oncol. 6, 503\u2013513 (2010).","journal-title":"Future Oncol."},{"key":"123_CR15","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/ijo.2010.105","volume":"34","author":"C Bing","year":"2010","unstructured":"Bing, C., Mracek, T., Gao, D. & Trayhurn, P. Zinc-2-glycoprotein: an adipokine modulator of body fat mass? Int. J. Obes. 34, 1559\u20131965 (2010).","journal-title":"Int. J. Obes."},{"key":"123_CR16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.drudis.2012.02.001","volume":"17","author":"JM Argil\u00e9s","year":"2012","unstructured":"Argil\u00e9s, J. M., Orp\u00ed, M., Busquets, S. & L\u00f3pez-Soriano, F. J. Myostatin: more than just a regulator of muscle mass. Drug Discov. Today. 17, 702\u2013709 (2012).","journal-title":"Drug Discov. Today."},{"key":"123_CR17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531\u2013543 (2010).","journal-title":"Cell"},{"key":"123_CR18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/1440-1681.12559","volume":"43","author":"M Bossola","year":"2016","unstructured":"Bossola, M., Marzetti, E., Rosa, F. & Pacelli, F. Skeletal muscle regeneration in cancer cachexia. Clin. Exp. Pharmacol. Physiol. 43, 522\u2013527 (2016).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"123_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2015.11.002","volume":"54","author":"M Sandri","year":"2016","unstructured":"Sandri, M. Protein breakdown in cancer cachexia. Semin. Cell Dev. Biol. 54, 11\u201319 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"123_CR20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1083\/jcb.201110067","volume":"198","author":"S Cohen","year":"2012","unstructured":"Cohen, S., Zhai, B., Gygi, S. P. & Goldberg, A. L. Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy. J. Cell Biol. 198, 575\u2013589 (2012).","journal-title":"J. Cell Biol."},{"key":"123_CR21","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.biocel.2005.03.010","volume":"37","author":"P Costelli","year":"2005","unstructured":"Costelli, P. et al. Ca2+-dependent proteolysis in muscle wasting. Int. J. Biochem. Cell Biol. 37, 2134\u20132146 (2005).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"123_CR22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0975-7406.76489","volume":"3","author":"S Jain","year":"2011","unstructured":"Jain, S., Gautam, V. & Naseem, S. Acute-phase proteins: as diagnostic tool. J. Pharm. Bioallied Sci. 3, 118\u2013127 (2011).","journal-title":"J. Pharm. Bioallied Sci."},{"key":"123_CR23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1006\/jsre.1993.1192","volume":"55","author":"C Andersson","year":"1993","unstructured":"Andersson, C., Gelin, J., Iresj\u00f6, B. M. & Lundholm, K. Acute-phase proteins in response to tumor growth. J.\u00a0Surg. Res. 55, 607\u2013614 (1993).","journal-title":"J. Surg. Res."},{"key":"123_CR24","volume":"7","author":"CH Richards","year":"2012","unstructured":"Richards, C. H. et al. The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLOS ONE 7, e41883 (2012).","journal-title":"PLOS ONE"},{"key":"123_CR25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fon.09.136","volume":"6","author":"CS Roxburgh","year":"2010","unstructured":"Roxburgh, C. S. & McMillan, D. C. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Futur. Oncol. 6, 149\u2013163 (2010).","journal-title":"Futur. Oncol."},{"key":"123_CR26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","volume":"104","author":"MJ Proctor","year":"2011","unstructured":"Proctor, M. J. et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br. J. Cancer 104, 726\u2013734 (2011).","journal-title":"Br. J. Cancer"},{"key":"123_CR27","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jpainsymman.2016.12.330","volume":"53","author":"CPL Simmons","year":"2017","unstructured":"Simmons, C. P. L. et al. Prognostic tools in patients with advanced cancer: a systematic review. J. Pain Symptom Manage. 53, 962\u2013970.e10 (2017).","journal-title":"J. Pain Symptom Manage."},{"key":"123_CR28","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2008060628","volume":"20","author":"L Zhang","year":"2009","unstructured":"Zhang, L. et al. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J.\u00a0Am. Soc. Nephrol. 20, 604\u2013612 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"123_CR29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/(SICI)1098-1128(199709)17:5<477::AID-MED3>3.0.CO;2-R","volume":"17","author":"JM Argil\u00e9s","year":"1997","unstructured":"Argil\u00e9s, J. M., Alvarez, B. & L\u00f3pez-Soriano, F. J. The metabolic basis of cancer cachexia. Med. Res. Rev. 17, 477\u2013498 (1997).","journal-title":"Med. Res. Rev."},{"key":"123_CR30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/01635581.2017.1247885","volume":"69","author":"O Prokopchuk","year":"2017","unstructured":"Prokopchuk, O. et al. IL-4 mRNA is downregulated in the liver of pancreatic cancer patients suffering from cachexia. Nutr. Cancer 69, 84\u201391 (2017).","journal-title":"Nutr. Cancer"},{"key":"123_CR31","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bbalip.2015.08.008","volume":"1851","author":"L Peyta","year":"2015","unstructured":"Peyta, L. et al. Regulation of hepatic cardiolipin metabolism by TNF-\u03b1: implication in cancer cachexia. Biochim. Biophys. Acta 1851, 1490\u20131500 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"123_CR32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fcell.2017.00090","volume":"75","author":"J Dudek","year":"2017","unstructured":"Dudek, J. Role of cardiolipin in mitochondrial signaling pathways. Front. Cell Dev. Biol. 75, 90 (2017).","journal-title":"Front. Cell Dev. Biol."},{"key":"123_CR33","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2337\/diabetes.54.8.2305","volume":"54","author":"GB Di Gregorio","year":"2005","unstructured":"Di Gregorio, G. B. et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54, 2305\u20132313 (2005).","journal-title":"Diabetes"},{"key":"123_CR34","first-page":"363","volume":"21","author":"ME Martignoni","year":"2009","unstructured":"Martignoni, M. E. et al. Liver macrophages contribute to pancreatic cancer-related cachexia. Oncol. Rep. 21, 363\u2013369 (2009).","journal-title":"Oncol. Rep."},{"key":"123_CR35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/SPC.0000000000000017","volume":"7","author":"GL1 Klein","year":"2013","unstructured":"Klein, G. L., Petschow, B. W., Shaw, A. L. & Weaver, E. Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target. Curr. Opin. Support Palliat. Care 7, 361\u2013367 (2013).","journal-title":"Curr. Opin. Support Palliat. Care"},{"key":"123_CR36","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","volume":"1812","author":"MJ Puppa","year":"2011","unstructured":"Puppa, M. J. et al. Gut barrier dysfunction in the Apc(Min\/+) mouse model of colon cancer cachexia. Biochim. Biophys. Acta 1812, 1601\u20131606 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"123_CR37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nrc2761","volume":"9","author":"DW Kufe","year":"2009","unstructured":"Kufe, D. W. Mucins in cancer: function, prognosis and therapy. Nat. Rev. Cancer 9, 874\u2013885 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"123_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fimmu.2013.00109","volume":"4","author":"M Matsuura","year":"2013","unstructured":"Matsuura, M. Structural modifications of bacterial lipopolysaccharide that facilitate Gram-negative bacteria evasion of host innate immunity. Front. Immunol. 4, 109 (2013).","journal-title":"Front. Immunol."},{"key":"123_CR39","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/carcin\/20.8.1425","volume":"20","author":"AP Soler","year":"1999","unstructured":"Soler, A. P. et al. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20, 1425\u20131431 (1999).","journal-title":"Carcinogenesis"},{"key":"123_CR40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10120-008-0497-0","volume":"12","author":"S Ohtani","year":"2009","unstructured":"Ohtani, S. et al. Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival. Gastr. Cancer 12, 43\u201351 (2009).","journal-title":"Gastr. Cancer"},{"key":"123_CR41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037971","volume":"7","author":"LB Bindels","year":"2012","unstructured":"Bindels, L. B. et al. Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLOS ONE 7, e37971 (2012).","journal-title":"PLOS ONE"},{"key":"123_CR42","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ismej.2015.209","volume":"10","author":"LB Bindels","year":"2016","unstructured":"Bindels, L. B. et al. Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia. ISME J. 10, 1456\u20131470 (2016).","journal-title":"ISME J."},{"key":"123_CR43","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.biocel.2013.06.021","volume":"45","author":"LB Bindels","year":"2013","unstructured":"Bindels, L. B. & Delzenne, N. M. Muscle wasting: the gut microbiota as a new therapeutic target? Int. J. Biochem. Cell Biol. 45, 2186\u20132190 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"123_CR44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe, M. et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484\u2013489 (2006).","journal-title":"Nature"},{"key":"123_CR45","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"S Manasa","year":"2015","unstructured":"Manasa, S. et al. Role of the normal gut microbiota. World J. Gastroenterol. 21, 8787\u20138803 (2015).","journal-title":"World J. Gastroenterol."},{"key":"123_CR46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00424-016-1933-3","volume":"469","author":"K Sakuma","year":"2017","unstructured":"Sakuma, K., Aoi, W. & Yamaguchi, A. Molecular mechanism of sarcopenia and cachexia: recent research advances. Pfl\u00fcgers Arch. 469, 573\u2013591 (2017).","journal-title":"Pfl\u00fcgers Arch."},{"key":"123_CR47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.0605374104","volume":"104","author":"F B\u00e4ckhed","year":"2007","unstructured":"B\u00e4ckhed, F., Manchester, J. K., Semenkovich, C. F. & Gordon, J. I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl Acad. Sci. USA 104, 979\u2013984 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"123_CR48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrendo.2011.126","volume":"7","author":"NM Delzenne","year":"2011","unstructured":"Delzenne, N. M., Neyrinck, A. M., B\u00e4ckhed, F. & Cani, P. D. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 7, 639\u2013646 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"123_CR49","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0607795103","volume":"103","author":"M Sandri","year":"2006","unstructured":"Sandri, M. et al. PGC-1\u03b1 protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl Acad. Sci. USA 103, 16260\u201316265 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"123_CR50","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","volume":"402","author":"M Kojima","year":"1999","unstructured":"Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656\u2013660 (1999).","journal-title":"Nature"},{"key":"123_CR51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yfrne.2009.10.008","volume":"31","author":"TR Casta\u00f1eda","year":"2010","unstructured":"Casta\u00f1eda, T. R., Tong, J., Datta, R., Culler, M. & Tsch\u00f6p, M. H. Ghrelin in the regulation of body weight and metabolism. Front. Neuroendocr. 31, 44\u201360 (2010).","journal-title":"Front. Neuroendocr."},{"key":"123_CR52","volume":"6","author":"L Sousa-Ferreira","year":"2011","unstructured":"Sousa-Ferreira, L. et al. Proliferative hypothalamic neurospheres express NPY, AGRP, POMC, CART and Orexin-A and differentiate to functional neurons. PLOS ONE 6, e19745 (2011).","journal-title":"PLOS ONE"},{"key":"123_CR53","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1210\/en.2002-220783","volume":"144","author":"K Choi","year":"2003","unstructured":"Choi, K. et al. The role of ghrelin and growth hormone secretagogues receptor on rat adipogenesis. Endocrinology 144, 754\u2013759 (2003).","journal-title":"Endocrinology"},{"key":"123_CR54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.regpep.2009.11.010","volume":"160","author":"A Mano-Otagiri","year":"2010","unstructured":"Mano-Otagiri, A. et al. Genetic suppression of ghrelin receptors activates brown adipocyte function and decreases fat storage in rats. Regul. Pept. 160, 81\u201390 (2010).","journal-title":"Regul. Pept."},{"key":"123_CR55","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1152\/ajpendo.00502.2006","volume":"292","author":"M Granado","year":"2007","unstructured":"Granado, M., Martin, A. I., Villanua, M. A. & Lopez-Calderon, A. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation. Am. J. Physiol. Endocrinol. Metab. 292, 1656\u20131665 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"123_CR56","doi-asserted-by":"crossref","first-page":"72872","DOI":"10.18632\/oncotarget.20531","volume":"8","author":"X Zeng","year":"2017","unstructured":"Zeng, X., Chen, S., Yang, Y. & Ke, Z. Acylated and unacylated ghrelin inhibit atrophy in myotubes co-cultured with colon carcinoma cells. Oncotarget 8, 72872\u201372885 (2017).","journal-title":"Oncotarget"},{"key":"123_CR57","first-page":"1387","volume":"39","author":"X Zeng","year":"2018","unstructured":"Zeng, X., Chen, S., Lin, Y. & Ke, Z. Acylated and unacylated ghrelin inhibit apoptosis in myoblasts cocultured with colon carcinoma cells. Oncol. Rep. 39, 1387\u20131395 (2018).","journal-title":"Oncol. Rep."},{"key":"123_CR58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12031-007-0004-9","volume":"33","author":"HS Wang","year":"2007","unstructured":"Wang, H. S., Oh, D. S., Ohning, G. V. & Pisegna, J. R. Elevated serum ghrelin exerts an orexigenic effect that may maintain body mass index in patients with metastatic neuroendocrine tumors. J. Mol. Neurosci. 33, 225\u2013231 (2007).","journal-title":"J. Mol. Neurosci."},{"key":"123_CR59","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.3748\/wjg.14.3633","volume":"14","author":"M Kerem","year":"2008","unstructured":"Kerem, M. et al. Adipokines and ghrelin in gastric cancer cachexia. World J. Gastroenterol. 14, 3633\u20133641 (2008).","journal-title":"World J. Gastroenterol."},{"key":"123_CR60","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10147-008-0856-1","volume":"14","author":"M Takahashi","year":"2009","unstructured":"Takahashi, M. et al. Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs. Int. J. Clin. Oncol. 14, 315\u2013320 (2009).","journal-title":"Int. J. Clin. Oncol."},{"key":"123_CR61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.lungcan.2009.02.006","volume":"66","author":"EM Karapanagiotou","year":"2009","unstructured":"Karapanagiotou, E. M. et al. Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients. Lung Cancer 66, 393\u2013398 (2009).","journal-title":"Lung Cancer"},{"key":"123_CR62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173113","volume":"12","author":"K Terawaki","year":"2017","unstructured":"Terawaki, K. et al. Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model. PLOS ONE 12, e0173113 (2017).","journal-title":"PLOS ONE"},{"key":"123_CR63","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.biopsych.2016.11.009","volume":"81","author":"ES Harmatz","year":"2017","unstructured":"Harmatz, E. S. et al. Central ghrelin resistance permits the overconsolidation of fear memory. Biol. Psychiatry. 81, 1003\u20131013 (2017).","journal-title":"Biol. Psychiatry."},{"key":"123_CR64","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.31128","volume":"124","author":"N Katakami","year":"2018","unstructured":"Katakami, N. et al. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer 124, 606\u2013616 (2018).","journal-title":"Cancer"},{"key":"123_CR65","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00520-016-3560-0","volume":"25","author":"Y Bai","year":"2017","unstructured":"Bai, Y. et al. Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis. Support. Care Cancer 25, 1651\u20131659 (2017).","journal-title":"Support. Care Cancer"},{"key":"123_CR66","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2147\/DDDT.S110131","volume":"11","author":"SA Graf","year":"2017","unstructured":"Graf, S. A. & Garcia, J. M. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy. Drug Des. Devel. Ther. 11, 2325\u20132331 (2017).","journal-title":"Drug Des. Devel. Ther."},{"key":"123_CR67","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2478\/v10181-011-0133-5","volume":"15","author":"K Majchrzak","year":"2012","unstructured":"Majchrzak, K., Szyszko, K., Paw\u0142owski, K. M., Motyl, T. & Kr\u00f3l, M. A role of ghrelin in cancerogenesis. Pol. J. Vet. Sci. 15, 189\u2013197 (2012).","journal-title":"Pol. J. Vet. Sci."},{"key":"123_CR68","doi-asserted-by":"crossref","first-page":"605193","DOI":"10.1155\/2011\/605193","volume":"2011","author":"JL Costa","year":"2011","unstructured":"Costa, J. L. et al. Ghrelin is an osteoblast mitogen and increases osteoclastic bone resorption in vitro. Int. J. Pept. 2011, 605193 (2011).","journal-title":"Int. J. Pept."},{"key":"123_CR69","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/164_2015_6","volume":"233","author":"M Giralt","year":"2016","unstructured":"Giralt, M., Cereijo, R. & Villarroya, F. Adipokines and the endocrine role of adipose tissues. Handb. Exp. Pharmacol. 233, 265\u2013282 (2016).","journal-title":"Handb. Exp. Pharmacol."},{"key":"123_CR70","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/1535370216683282","volume":"242","author":"JA Vaitkus","year":"2017","unstructured":"Vaitkus, J. A. & Celi, F. S. The role of adipose tissue in cancer-associated cachexia. Exp. Biol. Med. 242, 473\u2013481 (2017).","journal-title":"Exp. Biol. Med."},{"key":"123_CR71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11684-017-0555-2","volume":"12","author":"M Dong","year":"2018","unstructured":"Dong, M., Lin, J., Lim, W., Jin, W. & Lee, H. J. Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia. Front. Med. 12, 130\u2013138 (2018).","journal-title":"Front. Med."},{"key":"123_CR72","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/sj.bjc.6605665","volume":"102","author":"I Dahlman","year":"2010","unstructured":"Dahlman, I. et al. Adipose tissue pathways involved in weight loss of cancer cachexia. Br. J. Cancer 102, 1541\u20131548 (2010).","journal-title":"Br. J. Cancer"},{"key":"123_CR73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12944-017-0547-x","volume":"16","author":"R Silv\u00e9rio","year":"2017","unstructured":"Silv\u00e9rio, R. et al. Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer. Lipids Health Dis. 16, 159 (2017).","journal-title":"Lipids Health Dis."},{"key":"123_CR74","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40104-017-0174-4","volume":"8","author":"GA Contreras","year":"2017","unstructured":"Contreras, G. A., Strieder-Barboza, C. & Raphael, W. Adipose tissue lipolysis and remodeling during the transition period of dairy cows. J. Anim. Sci. Biotechnol. 8, 41 (2017).","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"123_CR75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cyto.2011.10.008","volume":"57","author":"ML Batista","year":"2012","unstructured":"Batista, M. L. et al. Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors. Cytokine 57, 9\u201316 (2012).","journal-title":"Cytokine"},{"key":"123_CR76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/SPC.0b013e3282f34738","volume":"1","author":"JM Argil\u00e9s","year":"2008","unstructured":"Argil\u00e9s, J. M., L\u00f3pez-Soriano, F. J. & Busquets, S. Mechanisms to explain wasting of muscle and fat in cancer cachexia. Curr. Opin. Support. Palliat. Care 1, 293\u2013298 (2008).","journal-title":"Support. Palliat. Care"},{"key":"123_CR77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12944-018-0657-0","volume":"17","author":"J Han","year":"2018","unstructured":"Han, J., Meng, Q., Shen, L. & Wu, G. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning. Lipids Health Dis. 17, 14 (2018).","journal-title":"Lipids Health Dis."},{"key":"123_CR78","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjc.6606083","volume":"104","author":"T Mracek","year":"2011","unstructured":"Mracek, T. et al. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br. J. Cancer 104, 441\u2013447 (2011).","journal-title":"Br. J. Cancer"},{"key":"123_CR79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","volume":"43","author":"EB Geer","year":"2014","unstructured":"Geer, E. B., Islam, J. & Buettner, C. Mechanisms of glucocorticoid-induced insulin resistance focus on adipose tissue function and lipid metabolism. Endocrinol. Metab. Clin. North Am. 43, 75\u2013102 (2014).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"123_CR80","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1210\/er.2017-00163","volume":"38","author":"A Abdullahi","year":"2017","unstructured":"Abdullahi, A. & Jeschke, M. G. Taming the flames: targeting white adipose tissue browning in hypermetabolic conditions. Endocr. Rev. 38, 538\u2013549 (2017).","journal-title":"Endocr. Rev."},{"key":"123_CR81","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.trecan.2016.07.005","volume":"2","author":"S Kir","year":"2016","unstructured":"Kir, S. & Spiegelman, B. M. Cachexia and brown fat: a burning issue in cancer. Trends Cancer 2, 461\u2013463 (2016).","journal-title":"Trends Cancer"},{"key":"123_CR82","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","volume":"20","author":"M Petruzzelli","year":"2014","unstructured":"Petruzzelli, M. et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 20, 433\u2013447 (2014).","journal-title":"Cell Metab."},{"key":"123_CR83","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/nm.4171","volume":"22","author":"M Rohm","year":"2016","unstructured":"Rohm, M. et al. An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice. Nat. Med. 22, 1120\u20131130 (2016).","journal-title":"Nat. Med."},{"key":"123_CR84","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1158\/0008-5472.CAN-11-3536","volume":"72","author":"M Tsoli","year":"2012","unstructured":"Tsoli, M. et al. Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice. Cancer Res. 72, 4372\u20134382 (2012).","journal-title":"Cancer Res."},{"key":"123_CR85","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4103\/0019-509X.175828","volume":"52","author":"S Basu","year":"2015","unstructured":"Basu, S. Hypothesizing association between cancer cachexia and Fluorodeoxyglucose-positron emission tomography documented brown adipose tissue hypermetabolism in cancer patients with an illustration in grossly emaciated cachectic patient in hot Indian summer climate: will beta blockers find use in the management of this condition? Indian J. Cancer 52, 223 (2015).","journal-title":"Indian J. Cancer"},{"key":"123_CR86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/med.20010","volume":"25","author":"JM Argil\u00e9s","year":"2005","unstructured":"Argil\u00e9s, J. M., L\u00f3pez-Soriano, J., Almendro, V., Busquets, S. & L\u00f3pez-Soriano, F. J. Cross-talk between skeletal muscle and adipose tissue: a link with obesity? Med. Res. Rev. 25, 49\u201365 (2005).","journal-title":"Med. Res. Rev."},{"key":"123_CR87","doi-asserted-by":"crossref","first-page":"139239","DOI":"10.1155\/2013\/139239","volume":"2013","author":"K Makki","year":"2013","unstructured":"Makki, K., Froguel, P. & Wolowczuk, I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013, 139239 (2013).","journal-title":"ISRN Inflamm."},{"key":"123_CR88","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.drudis.2008.10.010","volume":"14","author":"JM Argil\u00e9s","year":"2009","unstructured":"Argil\u00e9s, J. M., L\u00f3pez-Soriano, F. J. & Busquets, S. Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity. Drug Discov. Today 14, 208\u2013213 (2009).","journal-title":"Drug Discov. Today"},{"key":"123_CR89","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","volume":"333","author":"SK Das","year":"2011","unstructured":"Das, S. K. et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 333, 233\u2013238 (2011).","journal-title":"Science"},{"key":"123_CR90","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00018-016-2420-x","volume":"74","author":"S Wang","year":"2017","unstructured":"Wang, S. & Yang, X. Inter-organ regulation of adipose tissue browning. Cell. Mol. Life Sci. 74, 1765\u20131776 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"123_CR91","doi-asserted-by":"crossref","first-page":"E769","DOI":"10.1210\/jc.2012-2749","volume":"98","author":"JM Moreno-Navarrete","year":"2013","unstructured":"Moreno-Navarrete, J. M. et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J. Clin. Endocrinol. Metab. 98, E769\u2013E778 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"123_CR92","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m, P. et al. A PGC1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463\u2013468 (2012).","journal-title":"Nature"},{"key":"123_CR93","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1096\/fj.12-225755","volume":"27","author":"T Shan","year":"2013","unstructured":"Shan, T., Liang, X., Bi, P. & Kuang, S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1-Fndc5 pathway in muscle. FASEB J. 27, 1981\u20131989 (2013).","journal-title":"FASEB J."},{"key":"123_CR94","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.2337\/db13-1885","volume":"63","author":"A Carriere","year":"2014","unstructured":"Carriere, A. et al. Browning of white adipose cells by intermediate metabolites: an adaptive mechanism to alleviate redox pressure. Diabetes 63, 3253\u20133265 (2014).","journal-title":"Diabetes"},{"key":"123_CR95","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-011-0030-x","volume":"2","author":"NA Stephens","year":"2011","unstructured":"Stephens, N. A. et al. Intramyocellular lipid droplets increase with progression of cachexia in cancer patients. J. Cachexia Sarcopenia Muscle 2, 111\u2013117 (2011).","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"123_CR96","first-page":"61","volume":"6","author":"JL Ambrus","year":"1975","unstructured":"Ambrus, J. L., Ambrus, C. M., Mink, I. B. & Pickren, J. W. Causes of death in cancer patients. J. Med. 6, 61\u201364 (1975).","journal-title":"J. Med."},{"key":"123_CR97","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/SPC.0000000000000222","volume":"10","author":"D Dudgeon","year":"2016","unstructured":"Dudgeon, D. & Baracos, V. E. Physiological and functional failure in chronic obstructive pulmonary disease, congestive heart failure and cancer: a debilitating intersection of sarcopenia, cachexia and breathlessness. Curr. Opin.Support. Palliat. Care 10, 236\u2013241 (2016).","journal-title":"Support. Palliat. Care"},{"key":"123_CR98","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0022-4804(90)90112-F","volume":"49","author":"C Drott","year":"1990","unstructured":"Drott, C. & Lundholm, K. Glucose uptake and amino acid metabolism in perfused hearts from tumor-bearing rats. J. Surg. Res. 49, 62\u201368 (1990).","journal-title":"J. Surg. Res."},{"key":"123_CR99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0277-5379(91)90050-N","volume":"27","author":"A Hyltander","year":"1991","unstructured":"Hyltander, A., Drott, C., K\u00f6rner, U., Sandstr\u00f6m, R. & Lundholm, K. Elevated energy expenditure in cancer patients with solid tumours. Eur. J. Cancer 27, 9\u201315 (1991).","journal-title":"Eur. J. Cancer"},{"key":"123_CR100","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ehf2.12184","volume":"4","author":"A Barkhudaryan","year":"2017","unstructured":"Barkhudaryan, A., Scherbakov, N., Springer, J. & Doehner, W. Cardiac muscle wasting in individuals with cancer cachexia. ESC Heart Fail. 4, 458\u2013467 (2017).","journal-title":"ESC Heart Fail."},{"key":"123_CR101","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1743-7075-9-76","volume":"9","author":"M Olivan","year":"2012","unstructured":"Olivan, M. et al. Theophylline is able to partially revert cachexia in tumour-bearing rats. Nutr. Metab. 9, 76 (2012).","journal-title":"Nutr. Metab."},{"key":"123_CR102","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11883-017-0660-3","volume":"19","author":"LF Shirazi","year":"2017","unstructured":"Shirazi, L. F., Bissett, J., Romeo, F. & Mehta, J. L. Role of inflammation in heart failure. Curr. Atheroscler. Rep. 19, 27 (2017).","journal-title":"Curr. Atheroscler. Rep."},{"key":"123_CR103","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.3892\/or.2017.5542","volume":"37","author":"Y Belloum","year":"2017","unstructured":"Belloum, Y., Rannou-Bekono, F. & Favier, F. B. Cancer-induced cardiac cachexia: pathogenesis and impact of physical activity (Review). Oncol. Rep. 37, 2543\u20132552 (2017).","journal-title":"Oncol. Rep."},{"key":"123_CR104","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter, S., Gupta, S. C., Chaturvedi, M. M. & Aggarwal, B. B. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49, 1603\u20131616 (2010).","journal-title":"Free Radic. Biol. Med."},{"key":"123_CR105","first-page":"347","volume":"37","author":"M Tian","year":"2010","unstructured":"Tian, M. et al. Cardiac alterations in cancer-induced cachexia in mice. Int. J. Oncol. 37, 347\u2013353 (2010).","journal-title":"Int. J. Oncol."},{"key":"123_CR106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020424","volume":"6","author":"C M\u00fchlfeld","year":"2011","unstructured":"M\u00fchlfeld, C. et al. Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart. PLOS ONE 6, e20424 (2011).","journal-title":"PLOS ONE"},{"key":"123_CR107","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-10-3145","volume":"71","author":"PF Cosper","year":"2011","unstructured":"Cosper, P. F. & Leinwand, L. A. Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Res. 71, 1710\u20131720 (2011).","journal-title":"Cancer Res."},{"key":"123_CR108","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00395-017-0639-9","volume":"112","author":"TA Zimmers","year":"2017","unstructured":"Zimmers, T. A. et al. Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting. Basic Res. Cardiol. 112, 48 (2017).","journal-title":"Basic Res. Cardiol."},{"key":"123_CR109","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ajpath.2010.12.009","volume":"178","author":"A Wysong","year":"2011","unstructured":"Wysong, A. et al. NF-B inhibition protects against tumor-induced cardiac atrophy in vivo. Am. J. Pathol. 178, 1059\u20131068 (2011).","journal-title":"Am. J. Pathol."},{"key":"123_CR110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.coc.0000256101.04404.b0","volume":"30","author":"SC Burjonroppa","year":"2007","unstructured":"Burjonroppa, S. C. et al. Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload. Am. J. Clin. Oncol. 30, 287\u2013293 (2007).","journal-title":"Am. J. Clin. Oncol."},{"key":"123_CR111","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2174\/156652409789105499","volume":"9","author":"RH Ritchie","year":"2009","unstructured":"Ritchie, R. H., Rosenkranz, A. C. & Kaye, D. M. B-Type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target. Curr. Mol. Med. 9, 814\u2013825 (2009).","journal-title":"Curr. Mol. Med."},{"key":"123_CR112","first-page":"1321","volume":"39","author":"M Tian","year":"2011","unstructured":"Tian, M., Asp, M. L., Nishijima, Y. & Belury, M. A. Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice. Int. J. Oncol. 39, 1321\u20131326 (2011).","journal-title":"Int. J. Oncol."},{"key":"123_CR113","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EC-14-0012","volume":"3","author":"T Ogawa","year":"2014","unstructured":"Ogawa, T. & de Bold, A. J. The heart as an endocrine organ. Endocr. Connect. 3, R31\u2013R44 (2014).","journal-title":"Endocr. Connect."},{"key":"123_CR114","first-page":"245","volume":"127","author":"P Delafontaine","year":"2016","unstructured":"Delafontaine, P. & Yoshida, T. The renin-angiotensin system and the biology of skeletal muscle: mechanisms of muscle wasting in chronic disease states. Trans. Am. Clin. Climatol. Assoc. 127, 245\u2013258 (2016).","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"123_CR115","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.2016.3","volume":"114","author":"CA Penafuerte","year":"2016","unstructured":"Penafuerte, C. A. et al. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia. Br. J. Cancer 114, 680\u2013687 (2016).","journal-title":"Br. J. Cancer"},{"key":"123_CR116","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1073\/pnas.83.13.4769","volume":"83","author":"A Kurtz","year":"1986","unstructured":"Kurtz, A., Della Bruna, R., Pfeilschifter, J., Taugner, R. & Bauer, C. Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proc. Natl Acad. Sci. USA 83, 4769\u20134773 (1986).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"123_CR117","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.2337\/dc14-0669","volume":"37","author":"G Gruden","year":"2014","unstructured":"Gruden, G., Landi, A. & Bruno G. Natriuretic peptides, heart, and adipose tissue: new findings and future developments for diabetes research. Diabetes Care. 37, 2899\u20132908 (2014).","journal-title":"Diabetes Care."},{"key":"123_CR118","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1073\/pnas.1417273112","volume":"112","author":"T Nojiri","year":"2015","unstructured":"Nojiri, T. et al. Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells. Proc. Natl Acad. Sci. USA 112, 4086\u20134091 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"123_CR119","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13539-012-0064-8","volume":"3","author":"TS Solheim","year":"2012","unstructured":"Solheim, T. S. et al. Is there a genetic cause of appetite loss? \u2014 an explorative study in 1,853 cancer patients. J. Cachexia Sarcopenia Muscle 3, 191\u2013198 (2012).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"123_CR120","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MCO.0000000000000401","volume":"20","author":"K van Norren","year":"2017","unstructured":"van Norren, K., Dwarkasing, J. T. & Witkamp, R. F. The role of hypothalamic inflammation, the hypothalamic\u2013pituitary\u2013adrenal axis and serotonin in the cancer anorexia\u2013cachexia syndrome. Curr. Opin. Clin. Nutr. Metab. Care 20, 396\u2013401 (2017).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"123_CR121","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1749-6632.2011.06388.x","volume":"1243","author":"D Cai","year":"2011","unstructured":"Cai, D. & Liu, T. Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann. NY Acad. Sci. 1243, E1\u2013E39 (2011).","journal-title":"Ann. NY Acad. Sci."},{"key":"123_CR122","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2015.10.038","volume":"54","author":"KG Burfeind","year":"2016","unstructured":"Burfeind, K. G., Michaelis, K. A. & Marksa, D. L. The central role of hypothalamic inflammation in the acute illness response and cachexia. Semin. Cell Dev. Biol. 54, 42\u201352 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"123_CR123","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/jcsm.12008","volume":"6","author":"JT Dwarkasing","year":"2015","unstructured":"Dwarkasing, J. T. et al. Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling. J. Cachexia Sarcopenia Muscle 6, 84\u201394 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"123_CR124","doi-asserted-by":"crossref","DOI":"10.1186\/s12868-016-0260-0","volume":"17","author":"JT Dwarkasing","year":"2016","unstructured":"Dwarkasing, J. T. et al. Increased hypothalamic serotonin turnover in inflammation-induced anorexia. BMC Neurosci. 17, 26 (2016).","journal-title":"BMC Neurosci."},{"key":"123_CR125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/jcsm.12156","volume":"8","author":"A Molfino","year":"2017","unstructured":"Molfino, A. et al. Cancer anorexia: hypothalamic activity and its association with inflammation and appetite-regulating peptides in lung cancer. J. Cachexia Sarcopenia Muscle 8, 40\u201347 (2017).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"123_CR126","first-page":"3347","volume":"45","author":"WK Evans","year":"1985","unstructured":"Evans, W. K. et al. Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer. Cancer Res. 45, 3347\u20133353 (1985).","journal-title":"Cancer Res."},{"key":"123_CR127","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-2895-8_7","volume":"872","author":"SC Bodine","year":"2015","unstructured":"Bodine, S. C. & Furlow, J. D. Glucocorticoids and skeletal muscle. Adv. Exp. Med. Biol. 872, 145\u2013176 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"123_CR128","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.peptides.2006.11.021","volume":"28","author":"MA Joppa","year":"2007","unstructured":"Joppa, M. A., Gogas, K. R., Foster, A. C. & Markison, S. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83\u2013132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice. Peptides 28, 636\u2013642 (2007).","journal-title":"Peptides"},{"key":"123_CR129","doi-asserted-by":"crossref","first-page":"F1315","DOI":"10.1152\/ajprenal.00341.2012","volume":"303","author":"WW Cheung","year":"2012","unstructured":"Cheung, W. W. & Mak, R. H. Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease. Am. J. Physiol. Renal Physiol. 303, F1315\u2013F1324 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"123_CR130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fphys.2017.00134","volume":"8","author":"B Murtaza","year":"2017","unstructured":"Murtaza, B. et al. Alteration in taste perception in cancer: causes and strategies of treatment. Front. Physiol. 8, 134 (2017).","journal-title":"Front. Physiol."},{"key":"123_CR131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1586\/14737140.2.1.121","volume":"2","author":"A Tohgo","year":"2002","unstructured":"Tohgo, A., Kumazawa, E., Akahane, K., Asakawa, A. & Inui, A. Anticancer drugs that induce cancer-associated cachectic syndromes. Expert Rev. Anticancer Ther. 2, 121\u2013129 (2002).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"123_CR132","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/SPC.0b013e32833ef813","volume":"4","author":"JB Hopkinson","year":"2010","unstructured":"Hopkinson, J. B. The emotional aspects of cancer anorexia. Curr. Opin. Support. Palliat. Care 4, 254\u2013258 (2010).","journal-title":"Support. Palliat. Care"},{"key":"123_CR133","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","volume":"6","author":"L Lerner","year":"2015","unstructured":"Lerner, L. et al. Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J. Cachexia Sarcopenia Muscle 6, 317\u2013324 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"123_CR134","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.molmed.2017.10.005","volume":"23","author":"SN Breit","year":"2017","unstructured":"Breit, S. N., Tsai, V. W.-W. & Brown, D. A. Targeting obesity and cachexia: identification of the GFRAL receptor\u2013MIC-1\/GDF15 pathway. Trends Mol. Med. 23, 1065\u20131067 (2017).","journal-title":"Trends Mol. Med."},{"key":"123_CR135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2017.12.024","volume":"131","author":"T Borner","year":"2018","unstructured":"Borner, T., Liberini, C. G., Lutz, T. A. & Riediger, T. Brainstem GLP-1 signalling contributes to cancer anorexia-cachexia syndrome in the rat. Neuropharmacology 131, 282\u2013290 (2018).","journal-title":"Neuropharmacology"},{"key":"123_CR136","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1463-1326.2012.01663.x","volume":"15","author":"AR Meloni","year":"2013","unstructured":"Meloni, A. R. et al. GLP-1 receptor activated insulin secretion from pancreatic-cells: mechanism and glucose dependence. Diabetes Obes. Metab. 15, 15\u201327 (2013).","journal-title":"Diabetes Obes. Metab."},{"key":"123_CR137","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","volume":"100","author":"AJ Grossberg","year":"2010","unstructured":"Grossberg, A. J., Scarlett, J. M. & Marks, D. L. Hypothalamic mechanisms in cachexia. Physiol. Behav. 100, 478\u2013489 (2010).","journal-title":"Physiol. Behav."},{"key":"123_CR138","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/SPC.0b013e32833e4aa5","volume":"4","author":"A Molfino","year":"2010","unstructured":"Molfino, A., Laviano, A. & Rossi Fanelli, F. Contribution of anorexia to tissue wasting in cachexia. Curr. Opin.Support. Palliat. Care 4, 249\u2013253 (2010).","journal-title":"Support. Palliat. Care"},{"key":"123_CR139","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fphys.2016.00679","volume":"7","author":"A Bonetto","year":"2017","unstructured":"Bonetto, A. et al. Differential bone loss in mouse models of colon cancer cachexia. Front. Physiol. 7, 679 (2017).","journal-title":"Front. Physiol."},{"key":"123_CR140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11914-017-0344-5","volume":"15","author":"JN Regan","year":"2017","unstructured":"Regan, J. N., Trivedi, T., Guise, T. A. & Waning, D. L. The role of TGF in bone-muscle crosstalk. Curr. Osteoporos. Rep. 15, 18\u201323 (2017).","journal-title":"Curr. Osteoporos. Rep."},{"key":"123_CR141","doi-asserted-by":"crossref","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","volume":"296","author":"R Sartori","year":"2009","unstructured":"Sartori, R. et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am. J. Physiol. Cell Physiol. 296, C1248\u2013C1257 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"123_CR142","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bone.2018.01.004","volume":"108","author":"L Chambard","year":"2018","unstructured":"Chambard, L. et al. Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers. Bone 108, 202\u2013209 (2018).","journal-title":"Bone"},{"key":"123_CR143","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fendo.2017.00358","volume":"8","author":"JN Regan","year":"2017","unstructured":"Regan, J. N. et al. Osteolytic breast cancer causes skeletal muscle weakness in an immunocompetent syngeneic mouse model. Front. Endocrinol. 8, 358 (2017).","journal-title":"Front. Endocrinol."},{"key":"123_CR144","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1085\/jgp.201711878","volume":"149","author":"G Meissner","year":"2017","unstructured":"Meissner, G. The structural basis of ryanodine receptor ion channel function. J. Gen. Physiol. 149, 1065\u20131089 (2017).","journal-title":"J. Gen. Physiol."},{"key":"123_CR145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/cjpp-2014-0463","volume":"93","author":"AN Stammers","year":"2015","unstructured":"Stammers, A. N. et al. The regulation of sarco(endo)plasmic reticulum calcium-ATPases (SERCA). Can. J. Physiol. Pharmacol. 93, 1\u201312 (2015).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"123_CR146","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mce.2015.10.017","volume":"432","author":"MR Laurent","year":"2016","unstructured":"Laurent, M. R. et al. Muscle-bone interactions: From experimental models to the clinic? A critical update. Mol. Cell. Endocrinol. 432, 14\u201336 (2016).","journal-title":"Mol. Cell. Endocrinol."},{"key":"123_CR147","first-page":"E191","volume":"296","author":"LS Quinn","year":"2009","unstructured":"Quinn, L. S., Anderson, B. G., Strait-Bodey, L., Stroud, A. M. & Argil\u00e9s, J. M. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am. J. Physiol. Metab. 296, E191\u2013E202 (2009).","journal-title":"Am. J. Physiol. Metab."},{"key":"123_CR148","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3892\/or.2012.1928","volume":"28","author":"PL Mart\u00ednez-Hern\u00e1ndez","year":"2012","unstructured":"Mart\u00ednez-Hern\u00e1ndez, P. L. et al. Serum interleukin-15 levels in cancer patients with cachexia. Oncol. Rep. 28, 1443\u20131452 (2012).","journal-title":"Oncol. Rep."},{"key":"123_CR149","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1042\/BCJ20170032","volume":"474","author":"JM Argiles","year":"2017","unstructured":"Argiles, J. M., L\u00f3pez-Soriano, F. J., Stemmler, B. & Busquets, S. Novel targeted therapies for cancer cachexia. Biochem. J. 474, 2663\u20132678 (2017).","journal-title":"Biochem. J."},{"key":"123_CR150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.currproblcancer.2011.01.001","volume":"35","author":"NP Gullett","year":"2011","unstructured":"Gullett, N. P. et al. Nutritional interventions for cancer-induced cachexia. Curr. Probl. Cancer 35, 58\u201390 (2011).","journal-title":"Curr. Probl. Cancer"},{"key":"123_CR151","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrgastro.2017.170","volume":"15","author":"NM Delzenne","year":"2017","unstructured":"Delzenne, N. M. & Bindels, L. B. Gut microbiota in 2017: contribution of gut microbiota\u2013host cooperation to drug efficacy. Nat. Rev. Gastroenterol. Hepatol. 15, 69\u201370 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"123_CR152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143080","volume":"10","author":"S Shrotriya","year":"2015","unstructured":"Shrotriya, S., Walsh, D., Bennani-Baiti, N., Thomas, S. & Lorton, C. C-Reactive protein is an important biomarker for prognosis tumor recurrence and treatment response in adult solid tumors: a systematic review. PLOS ONE 10, e0143080 (2015).","journal-title":"PLOS ONE"},{"key":"123_CR153","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fphys.2017.00092","volume":"8","author":"JM Argil\u00e9s","year":"2017","unstructured":"Argil\u00e9s, J. M. et al. Validation of the CAchexia SCOre (CASCO). Staging cancer patients: the use of minicasco as a simplified tool. Front. Physiol. 8, 92 (2017).","journal-title":"Front. Physiol."},{"key":"123_CR154","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrendo.2012.49","volume":"8","author":"BK Pedersen","year":"2012","unstructured":"Pedersen, B. K. & Febbraio, M. A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 8, 457\u2013465 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"123_CR155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13539-014-0154-x","volume":"5","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s, J. M. et al. Cachexia: a problem of energetic inefficiency. J. Cachexia Sarcopenia Muscle 5, 279\u2013286 (2014).","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"123_CR156","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/SPC.0000000000000300","volume":"11","author":"E Del Fabbro","year":"2017","unstructured":"Del Fabbro, E., Orr, T. A. & Stella, S. M. Practical approaches to managing cancer patients with weight loss. Curr. Opin. Support. Palliat. Care 11, 272\u2013277 (2017).","journal-title":"Curr. Opin. Support Palliat. Care."},{"key":"123_CR157","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.numecd.2007.06.004","volume":"18","author":"E Valassi","year":"2008","unstructured":"Valassi, E., Scacchi, M. & Cavagnini, F. Neuroendocrine control of food intake. Nutr. Metab. Cardiovasc. Dis. 18, 158\u2013168 (2008).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"123_CR158","first-page":"313","volume":"8","author":"J Lau","year":"2014","unstructured":"Lau, J. & Herzog, H. CART in the regulation of appetite and energy homeostasis. Front. Neurosci. 8, 313 (2014).","journal-title":"Front. Neurosci."},{"key":"123_CR159","first-page":"58","volume":"5","author":"CS Crespo","year":"2014","unstructured":"Crespo, C. S. et al. Peptides and food intake. Front. Endocrinol. 5, 58 (2014).","journal-title":"Front. Endocrinol."},{"key":"123_CR160","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmet.2007.09.012","volume":"6","author":"LH Tecott","year":"2007","unstructured":"Tecott, L. H. Serotonin and the orchestration of energy balance. Cell. Metabolism 6, 352\u2013361 (2007).","journal-title":"Cell. Metabolism"},{"key":"123_CR161","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1054\/jcaf.2003.4","volume":"9","author":"CH Davos","year":"2003","unstructured":"Davos, C. H. et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J. Card. Fail. 9, 29\u201335 (2003).","journal-title":"J. Card. Fail."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41574-018-0123-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-018-0123-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-018-0123-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:46:24Z","timestamp":1684619184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-018-0123-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["123"],"URL":"https:\/\/doi.org\/10.1038\/s41574-018-0123-0","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"21 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.S. is an employee of BSA Nutrition Center, which is a non-academic, for-profit affiliation. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}